IOVANCE BIOTHERAPEUTICS, INC. Quarterly Return On Assets in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Iovance Biotherapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q2 2024.
  • Iovance Biotherapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -50.8 %, a 15.3% increase year-over-year.
  • Iovance Biotherapeutics, Inc. annual Return On Assets for 2023 was -55.3 %, a 12% increase from 2022.
  • Iovance Biotherapeutics, Inc. annual Return On Assets for 2022 was -62.8 %, a 47.2% decline from 2021.
  • Iovance Biotherapeutics, Inc. annual Return On Assets for 2021 was -42.7 %, a 9.13% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -50.8 +9.21 +15.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -55.2 +7.07 +11.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -55.3 +7.54 +12% Oct 1, 2023 Dec 31, 2023
Q3 2023 -55.9 +3.28 +5.54% Jul 1, 2023 Sep 30, 2023
Q2 2023 -60 -8.41 -16.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -62.2 -16.9 -37.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -62.8 -20.1 -47.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -59.2 -20.3 -52.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -51.6 -15.6 -43.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -45.4 -11.3 -33.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -42.7 -3.57 -9.13% Oct 1, 2021 Dec 31, 2021
Q3 2021 -38.9 +6.73 +14.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -36 +17.2 +32.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -34 +28.8 +45.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -39.1 +9.16 +19% Oct 1, 2020 Dec 31, 2020
Q3 2020 -45.6 -8.08 -21.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -53.2 -16.6 -45.4% Apr 1, 2020 Jun 30, 2020
Q1 2020 -62.9 -27.1 -75.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 -48.3 -11.5 -31.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 -37.6 +8.35 +18.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -36.6 +9.06 +19.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 -35.8 +14.8 +29.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 -36.8 +22.4 +37.8% Oct 1, 2018 Dec 31, 2018
Q3 2018 -45.9 +5.34 +10.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 -45.7 +33.4 +42.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -50.6 +15.5 +23.5% Jan 1, 2018 Mar 31, 2018
Q4 2017 -59.1 +3.99 +6.32% Oct 1, 2017 Dec 31, 2017
Q3 2017 -51.3 +14 +21.5% Jul 1, 2017 Sep 30, 2017
Q2 2017 -79 -52.1 -194% Apr 1, 2017 Jun 30, 2017
Q1 2017 -66.1 -39.1 -145% Jan 1, 2017 Mar 31, 2017
Q4 2016 -63.1 -38.3 -155% Oct 1, 2016 Dec 31, 2016
Q3 2016 -65.3 -40.5 -164% Jul 1, 2016 Sep 30, 2016
Q2 2016 -26.9 -0.44 -1.66% Apr 1, 2016 Jun 30, 2016
Q1 2016 -27 +3.77 +12.3% Jan 1, 2016 Mar 31, 2016
Q4 2015 -24.8 +23.1 +48.2% Oct 1, 2015 Dec 31, 2015
Q3 2015 -24.8 +77.4 +75.8% Jul 1, 2015 Sep 30, 2015
Q2 2015 -26.5 +18.5 +41.1% Apr 1, 2015 Jun 30, 2015
Q1 2015 -30.8 +20.6 +40.1% Jan 1, 2015 Mar 31, 2015
Q4 2014 -47.9 +5.8 +10.8% Oct 1, 2014 Dec 31, 2014
Q3 2014 -102 -77.6 -315% Jul 1, 2014 Sep 30, 2014
Q2 2014 -44.9 +939 +95.4% Apr 1, 2014 Jun 30, 2014
Q1 2014 -51.4 -3.78K -101% Jan 1, 2014 Mar 31, 2014
Q4 2013 -53.7 +6.54K +99.2% Oct 1, 2013 Dec 31, 2013
Q3 2013 -24.6 +8.16K +99.7% Jul 1, 2013 Sep 30, 2013
Q2 2013 -984 +970 +49.6% Apr 1, 2013 Jun 30, 2013
Q1 2013 3.73K +6.45K Jan 1, 2013 Mar 31, 2013
Q4 2012 -6.6K Oct 1, 2012 Dec 31, 2012
Q3 2012 -8.18K Jul 1, 2012 Sep 30, 2012
Q2 2012 -1.95K Apr 1, 2012 Jun 30, 2012
Q1 2012 -2.72K Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.